Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    6183586 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Deferoxamine for the Treatment of Hemochromatosis
Conditions: Diabetes Mellitus;   Heart Disease;   Hemochromatosis;   Thalassemia
Intervention:

Study has passed its completion date and status has not been verified in more than two years.